• Apple is closing stores in these 11 states amid new coronavirus outbreaks
    Yahoo Finance

    Apple is closing stores in these 11 states amid new coronavirus outbreaks

    Apple is closing 77 stores across 11 states that are seeing new coronavirus spikes.

  • Economist: 'It’s absolutely critical' that extra unemployment benefits are extended by Congress
    Yahoo Money

    Economist: 'It’s absolutely critical' that extra unemployment benefits are extended by Congress

    As the U.S. continues to battle the coronavirus pandemic, with cases surging in the south and west, one deadline is keeping economists awake at night.

  • European stocks surge as U.S. economy adds 4.8 million jobs in June
    MarketWatch

    European stocks surge as U.S. economy adds 4.8 million jobs in June

    European stocks surged on Thursday as the U.S. economy regained 4.8 million jobs in June, adding to the global optimism engulfing investors.

  • Lemonade IPO: 5 things to know about the online insurer
    MarketWatch

    Lemonade IPO: 5 things to know about the online insurer

    As the world is buffeted by digital and societal revolutions, Lemonade Inc. is hoping to leverage the uncertainty created by those upheavals to reshape an industry meant to provide peace of mind: insurance.

  • ProAssurance Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In ProAssurance Corporation To Contact The Firm
    Newsfile

    ProAssurance Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In ProAssurance Corporation To Contact The Firm

    New York, New York--(Newsfile Corp. - July 2, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ProAssurance Corporation ("ProAssurance" or the "Company") (NYSE: PRA) of the August 17, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in ProAssurance stock or options between April 26, 2019 and May 7, 2020 ...

  • Hard Money Lender Combats Common Industry Misconceptions
    PR Newswire

    Hard Money Lender Combats Common Industry Misconceptions

    Ignite Funding earned the highest compliance examination score a licensed mortgage broker can achieve from the Nevada Division of Mortgage Lending. Nevada has some of the most stringent licensing requirements, lending practice regulations and oversight in the nation.

  • Pro soccer league allows players to skip U.S. National anthem
    Yahoo Finance Video

    Pro soccer league allows players to skip U.S. National anthem

    The National Women's Soccer League is now giving players the option to skip the national anthem and stay in the locker room to support the movement for racial justice.

  • Berkeley's Innovative Genomics Institute is rolling out a spit test for COVID-19 testing
    TechCrunch

    Berkeley's Innovative Genomics Institute is rolling out a spit test for COVID-19 testing

    Scientists from the University of California, Berkeley, have begun trials of a new spit test for COVID-19 infections developed by the university's Innovative Genomics Institute. Since the disease was first identified on U.S. shores, the Berkeley research institute led by the trailblazing CRISPR researcher Jennifer Doudna has worked tirelessly to bring innovative methods to diagnose and process viral samples and develop potential treatments for the disease to production. If the study proves that the new testing method can work as well as nasal swabs, then the Berkeley campus will be able to increase testing of students, faculty and staff ahead of the beginning of the school's fall semester in late August, according to a statement from the University.

  • Justin Chon’s ‘Blue Bayou’ Sells to Focus Features Out of Cannes Virtual Market (EXCLUSIVE)
    Variety

    Justin Chon’s ‘Blue Bayou’ Sells to Focus Features Out of Cannes Virtual Market (EXCLUSIVE)

    The latest project from acclaimed independent filmmaker Justin Chon, "Blue Bayou," has been acquired by Focus Features, Variety can report exclusively. The studio brokered a worldwide deal for the film's distribution rights out of the Cannes 2020 virtual market, which was financed by MARCO and Entertainment One. Focus will handle domestic, and its parent Universal […]

  • Fox Business

    Walmart parking lots to host drive-in movie series at 160 stores nationwide

    Walmart will be hosting drive-in movies at 160 locations across the U.S. starting in August.

  • Inside TV’s Fashion Design Competition Series Trend With ‘Project Runway,’ ‘Making the Cut,’ ‘Next in Fashion’
    Variety

    Inside TV’s Fashion Design Competition Series Trend With ‘Project Runway,’ ‘Making the Cut,’ ‘Next in Fashion’

    When “Project Runway” premiered on Bravo in 2004, it entered a crowded reality competition landscape but still managed to be the first of its kind as a fashion design competition. Now, more than a decade and a half later, such fashion series are seeing a surge. “Project Runway” alone has launched more than six spinoffs, […]

  • GlobeNewswire

    DEADLINE ALERT for KNDI, PRA, CODX, ENPH: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

    BENSALEM, Pa., July 02, 2020 -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following.

  • GlobeNewswire

    Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Elanco Animal Health Incorporated (ELAN)

    If you suffered a loss on your Elanco investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information https://www.glancylaw.com/cases/elanco-animal-health-incorporated/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights. On May 7, 2020, before the market opened, Elanco announced its first quarter 2020 financial results, reporting revenue of $657.7 million and earnings per share of -$0.12, reflecting “a reduction of approximately $60 million in channel inventory.”

  • China tech giant Alibaba dismisses livestreaming head, citing nepotism, gifts: document
    Reuters

    China tech giant Alibaba dismisses livestreaming head, citing nepotism, gifts: document

    Chinese e-commerce giant Alibaba Group Holding Ltd has fired Zhao Yan, the head of its fast-growing livestreaming division, on grounds of nepotism and accepting gifts, according to an internal memo announcing his termination, seen by Reuters. The undated document, produced by Alibaba's human resources department and published on June 29 on the company's internal intranet for staff, says Zhao was fired after he used his position to help third-party livestreamers score favorable positioning on Taobao Live, Alibaba's main platform for live-streamed e-commerce.

  • Peptide Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)
    PR Newswire

    Peptide Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)

    The peptide therapeutics market is projected to grow with a CAGR of nearly 10.19% over the forecast period. The major factor attributing to the growth of the market is the growing incidence of metabolic disorders and cancers. According to the National Institute of Health (NIH), in 2018, an estimated 1,735,350 new cases of cancer will be detected in the United States and 609,640 people will die from the disease. Furthermore, the increasing demand for efficient and low-cost drugs and rising investments in research and development of novel drugs boost market growth. However, the limitations associated with peptides and stringent regulatory requirements for drug approval are the major factors restraining market growth.Read the full report: https://www.reportlinker.com/p05917988/?utm_source=PRN Key Market TrendsCancer Segment to Dominate the Market Over the Forecast PeriodPeptides offer favorable prospects in targeted drug delivery for cancer due to their high specificity, discernment, small sizes, ease of modification, and high biocompatibility. The increasing frequency of cancer globally and increasing prescription of peptide therapeutics for cancer treatment are the key factors responsible for the dominance of this segment.According to the World Health Organization (WHO) cancer is the second prominent cause of death worldwide and is accountable for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Furthermore, rising awareness among patients and healthcare professionals regarding adverse effects of chemotherapy and radiation therapy is a major factor for growing focus towards alternative therapeutics such as peptide-based drugs.North America Dominates the Market and Expected to do Same in the Forecast PeriodNorth America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as a rise in awareness levels relating to peptide therapeutics products, increasing necessity for diagnostics in cancer and other diseases, and growing biotechnology industry.Increasing research and development expenditure by government and key players is also expected to help peptide therapeutics sustain dominance over the coming years. A properly established biopharmaceutical & pharmaceutical industry in this region is a major factor responsible for growth. In the North America region, the United States holds the largest market share due to factors such as an increasing number of research programs in the medical industry, along with a growing number of diseases in the country, which is anticipated to stimulate the demand in this region.Competitive LandscapeThe peptide therapeutics market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Eli Lilly and Company; Pfizer, Inc.; Amgen, Inc.; Bristol-Myers Squibb; EVER NEURO PHARMA GMBH; Takeda Pharmaceutical Company Limited; Teva Pharmaceuticals Industries Ltd.; AstraZeneca PLC; GlaxoSmithKline plc; and Novo Nordisk A/S.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p05917988/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • Dodge Introduces 'Demon-possessed' 2021 Dodge Charger SRT Hellcat Redeye
    PR Newswire

    Dodge Introduces 'Demon-possessed' 2021 Dodge Charger SRT Hellcat Redeye

    New 2021 Dodge Charger SRT Hellcat Redeye and its 797-horsepower supercharged HEMI® high-output engine drive the most powerful Charger lineup ever

  • 2020 Challenger SRT Super Stock Is the Newest Dodge Drag-racing Machine
    PR Newswire

    2020 Challenger SRT Super Stock Is the Newest Dodge Drag-racing Machine

    The 2020 Dodge Challenger SRT Super Stock is powered by the same supercharged 6.2-liter HEMI® high-output V-8 that powers the SRT Hellcat Redeye, but features a revised powertrain calibration that increases power output to 807 horsepower

  • Cat Out of Hell: Dodge//SRT Introduces the Most Powerful SUV Ever - 2021 Durango SRT Hellcat
    PR Newswire

    Cat Out of Hell: Dodge//SRT Introduces the Most Powerful SUV Ever - 2021 Durango SRT Hellcat

    Powered by the proven supercharged 6.2-liter HEMI® Hellcat V-8 engine paired with the quick-shifting TorqueFlite 8HP95 eight-speed automatic transmission, the three-row muscle car Dodge Durango joins Challenger and Charger in Hellcat form, delivering 710 horsepower and 645 lb.-ft. of torque

  • GlobeNewswire

    Veðskuldabréfasjóður ÍV - Breytingar á sjóðstjórn

    Veðskuldabréfasjóður ÍV er sérhæfður sjóður í rekstri ÍV sjóða hf. í eigu fagfjárfesta. Sjóðurinn er útgefandi skuldabréfaflokksins VIV 14 1, sem skráður er á skipulegan.

  • Global Oil & Gas Downhole Cables Market Outlook (2019 to 2027) - Featuring ABB, Tratos & ZTT Among Others
    PR Newswire

    Global Oil & Gas Downhole Cables Market Outlook (2019 to 2027) - Featuring ABB, Tratos & ZTT Among Others

    The "Oil & Gas Downhole Cables - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

  • Google's Latest Attempt to Fight Back Against Amazon
    Motley Fool

    Google's Latest Attempt to Fight Back Against Amazon

    Amazon (NASDAQ: AMZN) has been stealing away Google's most valuable searches over the last several years. More product searches begin on Amazon.com than the search engine owned by Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL). In order to combat the growing popularity of product searches on Amazon, Google's offering brands and retailers free listings on its main search results.

  • Barrons.com

    Retirees, Beware These Tax Traps on Social Security and Medicare

    Seniors face multiple income traps, and it’s not just the rich. For instance, lower- and middle-income retirees get hit by the so-called tax torpedo as rising income causes their Social Security benefits to be taxed.

  • Business Wire

    Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ideanomics, Inc. (IDEX)

    Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ideanomics, Inc.

  • Reuters

    GLOBAL MARKETS-Stocks rise after strong U.S. jobs data; COVID-19 caution lingers

    World stocks rose for a fourth straight day on Thursday after U.S. payrolls increased by a record 4.8 million in June, but the dollar and Treasury debt prices also edged up, which suggested lingering concern about rising COVID-19 cases in many U.S. states. Benchmark 10-year notes last rose 3/32 in price to yield 0.6726%, from 0.682% late on Wednesday.

Al usar Yahoo aceptas que Yahoo y sus socios puedan utilizar cookies para personalización y otros fines